The Comparison of Clinical Epidemiology of Hospitalized Patients with COVID-19 during the Third and Fourth Waves of the Pandemic in Gorgan

Table 2

Comparison of medication prescribing among third and fourth wave COVID-19 cases.

Variables	Total (n = 930)	Third wave (n = 351)	Fourth wave (n = 579)	value
Remdesivir	638 (68.60%)	189 (53.84%)	449 (77.54%)	0.001
Favipiravir	531 (57.09%)	83 (23.64%)	448 (77.37%)	0.02
Dexamethasone	773 (83.11%)	260 (74.07%)	513 (88.60%)	0.001
Methylprednisolone	172 (18.49%)	77 (21.93%)	95 (16.49%)	0.03
Heparin	695 (74.73%)	220 (62.67%)	475 (82.03%)	0.001
Ceftriaxone	322 (34.62%)	128 (36.46%)	194 (33.50%)	0.04
Meropenem	222 (23.87%)	116 (33.04%)	106 (18.30%)	0.001
Ceftazidime	277 (29.78%)	87 (24.78%)	190 (32.81%)	0.009
Cefepime	210 (22.58%)	61 (17.37%)	149 (25.73%)	0.03
Levofloxacin	117 (25.58%)	24 (6.83%)	93 (16.06%)	0.001

Bold values mean p < 0.05 (Statistical significance).